Nuvation Bio Inc 短期证券 : $ 568.56 (2023年12月 最新)
Nuvation Bio Inc短期证券(Marketable Securities)的相关内容及计算方法如下:
短期证券是流动性非常强,可以以合理的价格快速转换为现金的一种证券,属于流动资产。
截至2023年12月, Nuvation Bio Inc 过去一季度 的 短期证券 为 $ 568.56。
点击上方“历史数据”快速查看Nuvation Bio Inc 短期证券的历史走势;
点击上方“解释说明”快速查看关于Nuvation Bio Inc 短期证券的详细说明;
点击上方“相关词条”快速查看与短期证券相关的其他指标。
Nuvation Bio Inc 短期证券 (NUVB.WS 短期证券) 历史数据
Nuvation Bio Inc 短期证券的历史年度,季度/半年度走势如下:
Nuvation Bio Inc 短期证券 年度数据 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日期 | 2020-12 | 2021-12 | 2022-12 | 2023-12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
短期证券 | 186.00 | 632.97 | 559.91 | 568.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nuvation Bio Inc 短期证券 季度数据 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
日期 | 2021-09 | 2021-12 | 2022-03 | 2022-06 | 2022-09 | 2022-12 | 2023-03 | 2023-06 | 2023-09 | 2023-12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
短期证券 | 447.15 | 632.97 | 631.50 | 601.48 | 535.26 | 559.91 | 616.54 | 580.84 | 594.94 | 568.56 |
Nuvation Bio Inc 短期证券 (NUVB.WS 短期证券) 解释说明
短期证券是流动性非常强,可以以合理的价格快速转换为现金的一种证券,属于流动资产。短期证券的到期日往往不到一年。
请注意,价值大师网的短期证券还包括“其他短期投资”。
Nuvation Bio Inc 短期证券 (NUVB.WS 短期证券) 相关词条
感谢查看价值大师中文站为您提供的Nuvation Bio Inc短期证券的详细介绍,请点击以下链接查看与Nuvation Bio Inc短期证券相关的其他词条:
Nuvation Bio Inc (NUVB.WS) 公司简介
一级行业:医疗保健
二级行业:生物科技
公司网站:https://www.nuvationbio.com
公司地址:1500 Broadway, Suite 1401, New York, NY, USA, 10036
公司简介:Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
二级行业:生物科技
公司网站:https://www.nuvationbio.com
公司地址:1500 Broadway, Suite 1401, New York, NY, USA, 10036
公司简介:Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).